These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 25884729)
1. The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma. Saito S; Morishima K; Ui T; Hoshino H; Matsubara D; Ishikawa S; Aburatani H; Fukayama M; Hosoya Y; Sata N; Lefor AK; Yasuda Y; Niki T BMC Cancer; 2015 Feb; 15():82. PubMed ID: 25884729 [TBL] [Abstract][Full Text] [Related]
2. Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met. Mueller KL; Madden JM; Zoratti GL; Kuperwasser C; List K; Boerner JL Breast Cancer Res; 2012 Jul; 14(4):R104. PubMed ID: 22788954 [TBL] [Abstract][Full Text] [Related]
3. FGFR inhibitor AZD4547 can enhance sensitivity of esophageal squamous cell carcinoma cells with epithelial‑mesenchymal transition to gefitinib. Luo H; Quan J; Xiao H; Luo J; Zhang Q; Pi G; Ye Y; He R; Liu Y; Su X; Zhao L; Wang G Oncol Rep; 2018 May; 39(5):2270-2278. PubMed ID: 29517107 [TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma. Maehara O; Suda G; Natsuizaka M; Ohnishi S; Komatsu Y; Sato F; Nakai M; Sho T; Morikawa K; Ogawa K; Shimazaki T; Kimura M; Asano A; Fujimoto Y; Ohashi S; Kagawa S; Kinugasa H; Naganuma S; Whelan KA; Nakagawa H; Nakagawa K; Takeda H; Sakamoto N Carcinogenesis; 2017 Oct; 38(11):1073-1083. PubMed ID: 28927233 [TBL] [Abstract][Full Text] [Related]
5. Lapatinib inhibits the growth of esophageal squamous cell carcinoma and synergistically interacts with 5-fluorouracil in patient-derived xenograft models. Hou W; Qin X; Zhu X; Fei M; Liu P; Liu L; Moon H; Zhang P; Greshock J; Bachman KE; Ye BC; Wang H; Zang CY Oncol Rep; 2013 Aug; 30(2):707-14. PubMed ID: 23708506 [TBL] [Abstract][Full Text] [Related]
6. MET activation mediates resistance to lapatinib inhibition of HER2-amplified gastric cancer cells. Chen CT; Kim H; Liska D; Gao S; Christensen JG; Weiser MR Mol Cancer Ther; 2012 Mar; 11(3):660-9. PubMed ID: 22238368 [TBL] [Abstract][Full Text] [Related]
7. Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion. Grugan KD; Miller CG; Yao Y; Michaylira CZ; Ohashi S; Klein-Szanto AJ; Diehl JA; Herlyn M; Han M; Nakagawa H; Rustgi AK Proc Natl Acad Sci U S A; 2010 Jun; 107(24):11026-31. PubMed ID: 20534479 [TBL] [Abstract][Full Text] [Related]
9. Paracrine receptor activation by microenvironment triggers bypass survival signals and ALK inhibitor resistance in EML4-ALK lung cancer cells. Yamada T; Takeuchi S; Nakade J; Kita K; Nakagawa T; Nanjo S; Nakamura T; Matsumoto K; Soda M; Mano H; Uenaka T; Yano S Clin Cancer Res; 2012 Jul; 18(13):3592-602. PubMed ID: 22553343 [TBL] [Abstract][Full Text] [Related]
10. The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis. Noma K; Smalley KS; Lioni M; Naomoto Y; Tanaka N; El-Deiry W; King AJ; Nakagawa H; Herlyn M Gastroenterology; 2008 Jun; 134(7):1981-93. PubMed ID: 18439605 [TBL] [Abstract][Full Text] [Related]
11. FGFR2 regulation by picrasidine Q inhibits the cell growth and induces apoptosis in esophageal squamous cell carcinoma. Shi Y; Liu X; Fredimoses M; Song M; Chen H; Liu K; Lee MH; Dong Z J Cell Biochem; 2018 Feb; 119(2):2231-2239. PubMed ID: 28857247 [TBL] [Abstract][Full Text] [Related]
12. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465 [TBL] [Abstract][Full Text] [Related]
13. HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer. Knowles LM; Stabile LP; Egloff AM; Rothstein ME; Thomas SM; Gubish CT; Lerner EC; Seethala RR; Suzuki S; Quesnelle KM; Morgan S; Ferris RL; Grandis JR; Siegfried JM Clin Cancer Res; 2009 Jun; 15(11):3740-50. PubMed ID: 19470725 [TBL] [Abstract][Full Text] [Related]
14. A receptor tyrosine kinase network composed of fibroblast growth factor receptors, epidermal growth factor receptor, v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, and hepatocyte growth factor receptor drives growth and survival of head and neck squamous carcinoma cell lines. Singleton KR; Kim J; Hinz TK; Marek LA; Casás-Selves M; Hatheway C; Tan AC; DeGregori J; Heasley LE Mol Pharmacol; 2013 Apr; 83(4):882-93. PubMed ID: 23371912 [TBL] [Abstract][Full Text] [Related]
15. [Tumor microenvironment elicits primary resistance to afatinib through HGF secretion]. Kang XH; Wang LF; Cao F; Fan FT; Xu ZY Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):732-6. PubMed ID: 24378092 [TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 7, secreted by breast fibroblasts, is an interleukin-1beta-induced paracrine growth factor for human breast cells. Palmieri C; Roberts-Clark D; Assadi-Sabet A; Coope RC; O'Hare M; Sunters A; Hanby A; Slade MJ; Gomm JJ; Lam EW; Coombes RC J Endocrinol; 2003 Apr; 177(1):65-81. PubMed ID: 12697038 [TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas. Ren Y; Cao B; Law S; Xie Y; Lee PY; Cheung L; Chen Y; Huang X; Chan HM; Zhao P; Luk J; Vande Woude G; Wong J Clin Cancer Res; 2005 Sep; 11(17):6190-7. PubMed ID: 16144920 [TBL] [Abstract][Full Text] [Related]
18. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Strutz F; Zeisberg M; Renziehausen A; Raschke B; Becker V; van Kooten C; Müller G Kidney Int; 2001 Feb; 59(2):579-92. PubMed ID: 11168939 [TBL] [Abstract][Full Text] [Related]
19. Esophageal squamous cell carcinoma invasion is inhibited by Activin A in ACVRIB-positive cells. Loomans HA; Arnold SA; Quast LL; Andl CD BMC Cancer; 2016 Nov; 16(1):873. PubMed ID: 27829391 [TBL] [Abstract][Full Text] [Related]
20. NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulates the survival and migration of tumor-associated macrophages and cancer cells. Takase N; Koma Y; Urakawa N; Nishio M; Arai N; Akiyama H; Shigeoka M; Kakeji Y; Yokozaki H Cancer Lett; 2016 Sep; 380(1):47-58. PubMed ID: 27317650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]